Obesity

Transitioning from having no metabolic abnormality nor obesity to metabolic impairment in a cohort of apparently healthy adults

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

Roughly one-quarter of apparently healthy adults are defined as "metabolically healthy" according to current definitions. The transition from health to metabolic dysfunction is accompanied with active inflammation and several non-metabolic syndrome biomarkers. Aggressive screening for these biomarkers, blood pressure and hs-CRP might help identify apparently healthy individuals at increased risk of developing metabolic syndrome over time.

Study context

Population
Apparently healthy adults attending their annual health survey, Tel Aviv Sourasky Medical Center Inflammation Survey (TAMCIS)
Participants
20,507 adults
Exposure
Metabolically healthy participants who developed metabolic impairment vs those consistently metabolically impaired
  • Became metabolically impairedn = 985
Outcome
Prevalence of metabolically healthy individuals (no metabolic syndrome criteria nor obesity)
Follow-up
Baseline
Methodological detailsfollow-up visit after 4.8 (± 0.6) years
  • Follow-up visit after 4.8 (± 0.6) years

Main finding

As reported in the abstract

No metabolic syndrome criteria at baseline

Did not fulfill any metabolic syndrome criteria at baseline

5379 individuals

26.2%

Observational data: associations, not effects.

Further findings

Developed metabolic criteria over time · follow-up

Developed metabolic criteria (of returning participants)
985 (12.7%)
Hypertension was the most prevalent component to develop

Metabolic syndrome criteria and elevated high sensitivity C-reactive protein (hs-CRP)

Those becoming metabolically impaired showed increased overlap between metabolic syndrome criteria and elevated hs-CRP

Delta values of biomarkers

Higher delta WBC, RBC, liver biomarkers and uric acid in those becoming impaired vs consistently impaired
LDL-C delta levels were similar

Original publication

Transitioning from having no metabolic abnormality nor obesity to metabolic impairment in a cohort of apparently healthy adults. Cardiovasc Diabetol. Published 26 August 2023. doi:10.1186/s12933-023-01954-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.